Urocanic acid
|
Basic information |
| Metabolite name | Urocanic acid |
 | HMDB0000301 |
 |
C00785 |
 |
736715 |
| Synonyms | Urocanate |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Urocanic acid |
| HMDB0000301 |
|
C00785 |
|
736715 |
| Synonyms | Urocanate |
| No. of studies | 10 |
|
Relationship between Urocanic acid and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Up |
| Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Up |
| Study M463 | Type3 | DG group vs. control group | Prefrontal cortex | C57BL/6J mouse | Down |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Up |
| Study M750 | Type2 | CUMS + CCFM1025 group vs. CUMS group | Faece | C57BL/6 mouse | Down |
| Study M756 | Type1 | depression group vs. control group | Serum | Human | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Faece | BALB/c mouse | Up |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Up |